Lexicon Pharmaceuticals
LXRX
#7142
Rank
$0.50 B
Marketcap
$1.40
Share price
-1.41%
Change (1 day)
97.18%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2025 (TTM): -$68.58 Million USD

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are $70.86 Million USD. In 2024 the company made an earning of -$0.21 Billion USD a decrease over its 2023 earnings that were of -$0.18 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$68.58 Million-65.78%
2024 -$0.21 Billion13.15%
2023 -$0.18 Billion73.74%
2022 -$0.11 Billion16.16%
2021 -$87.76 Million49.82%
2020 -$58.58 Million-147.19%
2019 $0.12 B-203.42%
2018 -$0.13 Billion-15.31%
2017 -$0.15 Billion0.2%
2016 -$0.15 Billion2920.7%
2015 -$4.69 Million-95.33%
2014 -$0.11 Billion-3.61%
2013 -$0.11 Billion-5.52%
2012 -$0.12 Billion-4.17%
2011 -$0.12 Billion15.5%
2010 -$99.58 Million8.36%
2009 -$91.9 Million-4.81%
2008 -$96.54 Million28.79%
2007 -$74.96 Million35.71%
2006 -$55.24 Million52.91%
2005 -$36.12 Million-23.89%
2004 -$47.46 Million-24.19%
2003 -$62.6 Million-0.48%
2002 -$62.9 Million44.12%
2001 -$43.64 Million23.01%
2000 -$35.48 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eterna Therapeutics
ERNA
-$9.49 Million-86.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$5.14 B-7,602.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-$0.52 Billion 656.31%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.67 B-1,090.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$7.09 B-10,447.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-$27.45 Million-59.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$0.99 B-1,550.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$66.79 M-197.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-$23.25 Million-66.11%๐Ÿ‡บ๐Ÿ‡ธ USA